Anderson KM, Higuchi TT, Flynn BJ. Management of the devastated posterior urethra and bladder neck: refractory incontinence and stenosis. Transl Androl Urol. 2015;4:60–5.
PubMed PubMed Central Google Scholar
Latini JM, McAninch JW, Brandes SB, Chung JY, Rosenstein D. IU/ICUD consultation on urethral strictures: Epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuries. Urology. 2014;83:S1.
Lumen N, Hoebeke P, Willemsen P, Troyer BD, Pieters R, Oosterlinck W. Etiology of urethral stricture disease in the 21st century. J Urol. 2009;182:983.
Mundy AR, Andrich DE. Posterior urethral complications of the treatment of prostate cancer. BJU Int. 2012;110:304–25.
Martins FE, Holm HV, Lumen N. Devastated bladder outlet in pelvic Cancer survivors: issues on surgical reconstruction and quality of life. J Clin Med. 2021;10(21):4920. https://doi.org/10.3390/jcm10214920.
Article CAS PubMed PubMed Central Google Scholar
Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll P. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE. J Urol. 2007;178:529.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Hamdy FC. Comment on “long-term quality of life in prostate cancer”. Lancet Oncol. 2011;12:832–3.
Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin F, et al. American Cancer Society prostate Cancer survivorship care guidelines. CA Cancer J Clin. 2014;64:225–49.
Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, Morgans AK, Penson DF. Prostate cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2015;33:1078–85.
Resncik MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436–45.
Johansson E, Steinneck G, Holmberg L, Joahnsson J-E, Nyberg T, Ruutu M, Bill-Axelson A. SPCG-4 investigators long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the scandinavian prostate Cancer Group-4 randomized trial. Lancet Oncol. 2011;12:891–9.
Jarosek SL, Virning BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67:173–80.
Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:40405.
Browne BM, Vanni AJ. Management of urethral stricture and bladder neck contracture following primary and salvage treatment of prostate cancer. Curr Urol Rep. 2017;18:76.
Oberlin DT, Flum AS, Lai JD, Meeks JJ. The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urol Oncol. 2016;34(6):255.e1–5. https://doi.org/10.1016/j.urolonc.2016.01.008.
Erickson BA, Meeks JJ, Roehl KA, Gonzalez CM, Catalona WJ. Bladder neck contracture after retropubic radical prostatectomy: incidence and risk factors from a large single-surgeon experience. BJU Int. 2009;104:1615–9.
Article PubMed PubMed Central Google Scholar
Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robotic-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010;106:1734–8.
Article PubMed PubMed Central Google Scholar
Parihar JS, Ha YS, Kim IY. Bladder neck contracture, incidence and management following contemporary robot assisted radical prostatectomy technique. Prostate Int. 2014;2:12–8.
Article PubMed PubMed Central Google Scholar
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181:956–62.
Article PubMed PubMed Central Google Scholar
Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003;76:590–9.
Article CAS PubMed Google Scholar
Villeirs L, Tailly T, Ost P, et al. Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: systematic review of the recent literature. Int J Urol. 2020;27(2):98–107. https://doi.org/10.1111/iju.14130.
Corcoran NM, Godoy G, Studd RC, Casey RG, Hurtado-Coll A, Tyldesly S, Goldenberg SL, Gleave ME. Salvage prostatectomy post-definitive radiation therapy: the vancouver experience. Can Urol Assoc J. 2013;7:87–92.
Article PubMed PubMed Central Google Scholar
Borboroglu PG, Sands JP, Roberts JL, Amling CL. Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology. 2000;56:96–100.
Article CAS PubMed Google Scholar
Hamdy FC, Donovan JL, Lane J, Mason M, Metcalfe C, Holding P, Davis M, Peters TJ, Turner EL, Martin RM, et al. 10-year outcomes after monitoring surgery or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415–24.
Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy. 2013;12:50–5.
Sullivan L, Williams SG, Tai KH, Faroudi F, Cleeve L, Duchesne GM. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;9:232–6.
Vora A, Agarwal V, Singh P, Patel R, Rivas R, Nething J, Muruve N. Single-institution comparative study on the outcomes of salvage cryotherapy versus salvage robotic prostatectomy for radio-resistant prostate cancer. Prostate Int. 2016;4:7–10.
Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN, Ganzer R, Chapet O, Gelet A, Chaussy CG, et al. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients. BJU Int. 2017;119:896–904.
Barrett E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset J, Validire P, Macek P, Durand M, Prapotnich D, Rozet F, et al. Morbidity of focal therapy in the treatment of localized prostate cancer. Eur Urol. 2013;63:618–22.
Muto S, Yoshi T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38:192–9.
Ward JF, Sebo TJ, Blute ML, Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005;173:1156–60.
Daly T, Hickey BE, Lehman M, Francis DP, See AM. Adjuvant radiotherapy following radical prostatectomy for prostate cancer. Cochrane Database Syst Rev. 2011;12:CD007234.
de la Taille A, Hayek O, Benson MC, Bagiella E, Olsson CA, Fatal M, Katz AE. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the columbia experience. Urology. 2000;55:79–84.
Comments (0)